shipment_ID,catalog_ID,Formula,stereochemistry,sample_MW,purity,PO,Salt_Name,Salt_ratio,MW_salt,volume(uL),concentration(mM),plate_ID,well,SMILES,Name
EDJ-MED-06d94977-1,Z4598794274,C18H19N5O2,Achiral,337.375,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-17,03_A,CCC(=O)NC=1C=CC(=CC1)N(C)C(=O)CN2N=NC=3C=CC=CC23,"N-{4-[2-(1H-1,2,3-benzotriazol-1-yl)-N-methylacetamido]phenyl}propanamide"
EDG-MED-0da5ad92-15,Z4497196459,C13H12ClN3O,Achiral,261.706,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-17,03_B,CC=1C=CN=NC1NC(=O)CC=2C=CC=C(Cl)C2,2-(3-chlorophenyl)-N-(4-methylpyridazin-3-yl)acetamide
EDJ-MED-50fe53e8-2,Z4616788943,C16H12ClN3O,Achiral,297.738,95.32,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-17,03_C,ClC=1C=CC=C(CC(=O)NC=2C=NN=C3C=CC=CC23)C1,2-(3-chlorophenyl)-N-(cinnolin-4-yl)acetamide
EDJ-MED-50fe53e8-3,Z4598794266,C15H12ClN3O,Achiral,285.728,97.49,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-17,03_D,ClC=1C=CC=C(CC(=O)NC=2N=CN3C=CC=CC23)C1,"2-(3-chlorophenyl)-N-{imidazo[1,5-a]pyridin-1-yl}acetamide"
MAT-POS-1e5f28a7-1,Z4610358502,C16H15ClN2O3,Racemic or presumed racemic or meso,318.754,82.72,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-17,03_E,COC(=O)C(C(=O)NC=1C=NC=CC1C)C=2C=CC=C(Cl)C2,methyl 2-(3-chlorophenyl)-2-[(4-methylpyridin-3-yl)carbamoyl]acetate
EDJ-MED-49816e9b-4,Z4497196447,C15H15ClN2O2S,Racemic or presumed racemic or meso,322.809,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-17,03_F,CC=1C=CN=CC1N2CCC(C=3C=CC=C(Cl)C3)S2(=O)=O,"5-(3-chlorophenyl)-2-(4-methylpyridin-3-yl)-1??,2-thiazolidine-1,1-dione"
